DDDR-35. TARGETING GBM INVASION BY INHIBITING KCNA1 WITH 4-AMINOPYRIDINE: AN FDA APPROVED DRUG THAT EASILY PASS THROUGH THE BBB

Authors: Sophie Xiao, Lin Li, Deying Yang, Huiyuan Zhang, Yulun Huang, Wan-Yee Teo, Akash Patel, Yuchen Du, Xiao-Nan Li

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.400

Source: Full article